Toxicity profile and clinical outcomes in locally advanced head and neck cancer patients treated with induction chemotherapy prior to concurrent chemoradiation

By Ko Eric C.   Genden Eric M.   Misiukiewicz Krzysztof   Som Peter M.   Kostakoglu Lale   Chen Chien-Ting   Packer Stuart   Kao Johnny  

Oncology Reports, Vol. 27, Iss. 2, 2012-02 ,pp. : 467-474

Spandidos Publications

Access to resources Recommend Favorite

The clinical significance of axillary sentinel lymph node biopsy in different clinical stages breast cancer patients after neoadjuvant chemotherapy

By Xu Juan   Wu Xinhong   Feng Yaojun   Yuan Feng   Fan Wei  

The Chinese-German Journal of Clinical Oncology, Vol. 12, Iss. 11, 2013-11 ,pp. : 521-523

Springer Publishing Company

Access to resources Recommend Favorite

Taxol as Second-Line Treatment in Patients with Advanced Ovarian Cancer after Platinum-Based First-Line Chemotherapy

By Mayerhofer K.   Kucera E.   Zeisler H.   Speiser P.   Reinthaller A.   Sevelda P.  

Gynecologic Oncology, Vol. 64, Iss. 1, 1997-01 ,pp. : 109-113

Elsevier

Access to resources Recommend Favorite

Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC)

By Holm Neal   Abreo Fleurette   Johnson Lester   Li Benjamin   Chu Quyen  

Breast Cancer Research and Treatment, Vol. 113, Iss. 2, 2009-01 ,pp. : 293-299

Springer Publishing Company

Access to resources Recommend Favorite

The surgical management of patients following neoadjuvant chemotherapy for locally advanced breast cancer

By Sauven P.  

European Journal of Cancer, Vol. 38, Iss. 18, 2002-12 ,pp. : 2371-2374

Elsevier

Access to resources Recommend Favorite